Yonemoto, Naohiro, Furuse, Junji, Okusaka, Takuji, Yamao, Kenji, Funakoshi, Akihiro, Ohkawa, Shinichi, ...
Background This study examined the effect of five systemic chemotherapy regimens on survival in patients with unresectable biliary tract cancer (BTC) as compared with the best supportive care (BSC). ...
Furuse, Junji, Okusaka, Takuji, Funakoshi, Akihiro, Yamao, Kenji, Nagase, Michitaka, Ishii, Hiroshi, ...
Background: Standard chemotherapy for advanced biliary tract cancer has not been established. The purpose of this study was to evaluate the efficacy and toxicity of a combination chemotherapy of...
Furuse, Junji, Okusaka, Takuji, Funakoshi, Akihiro, Yamao, Kenji, Nagase, Michitaka, Ishii, Hiroshi, ...
Background: Standard chemotherapy for advanced biliary tract cancer has not been established. The purpose of this study was to evaluate the efficacy and toxicity of a combination chemotherapy of...
Furuse, Junji, Ishii, Hiroshi, Okusaka, Takuji, Nagase, Michitaka, Nakachi, Kohei, Ueno, Hideki, ...
Objective: The purpose of this study was to determine the feasible dose of gemcitabine when administered as a fixed dose rate infusion (10 mg/m2/min) on a weekly schedule to Japanese patients with...
Furuse, Junji, Ishii, Hiroshi, Okusaka, Takuji, Nagase, Michitaka, Nakachi, Kohei, Ueno, Hideki, ...
Objective: The purpose of this study was to determine the feasible dose of gemcitabine when administered as a fixed dose rate infusion (10 mg/m2/min) on a weekly schedule to Japanese patients...
Furuse, Junji, Ishii, Hiroshi, Okusaka, Takuji, Nagase, Michitaka, Nakachi, Kohei, Ueno, Hideki, ...
Objective: The purpose of this study was to determine the feasible dose of gemcitabine when administered as a fixed dose rate infusion (10 mg/m2/min) on a weekly schedule to Japanese patients with...
Ishii, Hiroshi, Furuse, Junji, Nagase, Michitaka, Maru, Yasushi, Yoshino, Masahiro, Hayashi, Takayuki
Background: Hepatic arterial infusion of zinostatin stimalamer and lipiodol emulsion shows a moderate activity against hepatocellular carcinoma. However, the anti-tumor activity of zinostatin...